Medicare Drug Savings Act of 2017
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Medicare Drug Savings Act of 2017
This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services (CMS) for prescription drugs dispensed to eligible low-income individuals under the Medicare prescription drug benefit or a Medicare Advantage (MA) prescription drug plan (PDP).
Subject to civil monetary penalties, a Medicare or MA PDP sponsor must report, both to drug manufacturers and to the CMS, specified information related to the determination and payment of such rebates.
Read twice and referred to the Committee on Finance.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 252: Medicare Drug Savings Act of 2017. 115th Congress. Open America. https://openamerica.io/bill/115-S-252/
"S. 252: Medicare Drug Savings Act of 2017." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-252/.
S. 252, 115th Cong. (2026), https://openamerica.io/bill/115-S-252/.
[S. 252: Medicare Drug Savings Act of 2017](https://openamerica.io/bill/115-S-252/)